Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Hinge Health, Inc. (HNGE)

Hinge Health Q3 revenue rises 52% to $235 million and 2026 revenue guidance is raised

Positive Impact 4 of 5 earnings Written later

Hinge Health reported third-quarter 2026 revenue of $235.0 million, up 52% from a year earlier, and GAAP diluted net income of $0.66 per share compared with a loss of $0.02 per share in Q3 2025. The company raised its full-year 2026 revenue guidance to $879 million to $881 million and disclosed that President James Pursley will step down effective January 1, 2027, and join the Board on January 4, 2027.

Key points

  • Q3 2026 revenue was $235.0 million, up from $154.2 million in Q3 2025; GAAP income from operations was $50.3 million versus a $6.1 million loss a year earlier.
  • GAAP diluted EPS was $0.66 versus a loss of $0.02; non-GAAP diluted EPS was $0.71 versus $0.32.
  • Full-year 2026 revenue guidance was raised to $879 million to $881 million; Q4 2026 revenue is expected at $249 million to $251 million.
  • Free cash flow was $112.7 million in Q3 2026, versus $81.3 million a year earlier; Daniel Perez, CEO, will also become President.

The filing

CompanyHinge Health, Inc. (HNGE)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:06 PM ET
Accession number0001628280-26-068872

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.